CCCassie Chan

Cassie Chan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cassie Chan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Ashutosh Kumar

    Department of Neurology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA

    1 shared publication
  • Caroline Maltese

    Penn State Health College of Medicine, Hershey, PA, USA

    1 shared publication
  • Dustin Paul

    Department of Pediatrics and Neurology, Penn State Children’s Hospital, Penn State College of Medicine, Hershey, PA 17033, USA

    1 shared publication
  • Ermal Aliu

    Department of Genetics, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA

    1 shared publication
  • Lucy Emery

    Penn State Health College of Medicine, Hershey, PA, USA

    1 shared publication
  • Sunil Naik

    Department of Neurology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA

    1 shared publication

Latest Publications

  • Open Access

    A Novel Homozygous Variant in the CHRNE Gene in 2 Siblings with Congenital Myasthenic Syndrome

    by Cassie Chan, Lucy Emery, Caroline Maltese, Ashutosh Kumar, Ermal Aliu, Sunil Naik, Dustin Paul

    Cholinergic receptor nicotinic epsilon (CHRNE) subunit mutations cause postsynaptic type of congenital myasthenic syndrome either as a primary acetylcholine-receptor deficiency or abnormal channel kinetics in the receptor. We report a novel homozygous variant (c.322C > T, p.Pro108Ser) in the epsilon subunit causing primary acetylcholine-receptor deficiency in two siblings. Two siblings presented with fatigable weakness. Both siblings had whole exome sequencing showing a homozygous variant (c.322C > T, p.Pro108Ser) of unknown significance in the epsilon subunit. Electromyography/nerve conduction study with repetitive nerve stimulation on one sibling showed a defect in neuromuscular junction transmission. Pseudoephedrine and fluoxetine for suspected slow-channel congenital myasthenic syndrome yielded no improvement. A trial of pyridostigmine led to clinical improvement. Given the clinical presentation, consanguinity, homozygous genetic variant, and response to pyridostigmine, we rationalize the homozygous variant (c.322C > T, p.Pro108Ser) in cholinergic receptor nicotinic epsilon subunit causes the primary acetylcholine-receptor deficiency congenital myasthenic syndrome.